Dow Up0.26% Nasdaq Down1.07%

Teva Pharmaceutical Industries Limited (TEVA)

51.38 0.70(1.34%) Sep 15, 4:00PM EDT
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.2
Mean Recommendation (last week):2.3

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:60.68
Median Target:60.00
High Target:70.00
Low Target:48.00
No. of Brokers:25

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Jun 27, 2014Canaccord GenuityInitiated Hold
Jun 6, 2014ArgusUpgradeHoldBuy
Apr 7, 2014National Alliance SecuritiesInitiated Buy
Mar 7, 2014BarclaysUpgradeEqual WeightOverweight
Jan 7, 2014RBC Capital MktsInitiated Sector Perform
Jun 19, 2013Maxim GroupInitiated Buy
Feb 25, 2013ArgusDowngradeBuyHold
May 23, 2012AurigaInitiated Hold
May 10, 2012NeedhamDowngradeStrong BuyHold
Dec 9, 2011Barclays CapitalInitiated Equal Weight

More Upgrades & Downgrades for TEVA

Data provided by - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy7776

Data provided by Thomson/First Call

Currency in USD.